Infinium Pharmachem IPO vs Sancode Technologies IPO

Comparision between Infinium Pharmachem IPO and Sancode Technologies IPO.

IPO Details

Infinium Pharmachem IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Sancode Technologies IPO is a SME Fixed Price Issue proposed to list at BSE SME.

	Infinium Pharmachem IPO	Sancode Technologies IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Fixed Price Issue
Listing At	NSE SME	BSE SME
Lead Managers	Swastika Investmart Ltd	Shreni Shares Limited
Registrar	Bigshare Services Pvt Ltd	Bigshare Services Pvt Ltd
Market Maker	Swastika Investmart Limited	Shreni Shares Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Sancode Technologies IPO is up to ₹5.15 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Sancode Technologies IPO is ₹47.00 per share.

	Infinium Pharmachem IPO	Sancode Technologies IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)	₹135.00 per share	₹47.00 per share
Discount (Retail)
Discount (Employee)	₹13.50 per share
Market Lot Size	1000 shares	3000 shares
Fresh Issue Size	18,75,000 shares	10,95,000 shares
Fresh Issue Size (Amount)	up to ₹25.26 Cr	up to ₹5.15 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	18,75,000 shares	10,95,000 shares
Issue Size Total (Amount)	up to ₹25.26 Cr	up to ₹5.15 Cr

IPO Timetable

Infinium Pharmachem IPO opens on Mar 31, 2023, while Sancode Technologies IPO opens on Mar 31, 2023. The closing date of Infinium Pharmachem IPO and Sancode Technologies IPO is Apr 05, 2023, and Apr 06, 2023, respectively.

	Infinium Pharmachem IPO	Sancode Technologies IPO
Anchor Bid Date
Issue Open	Mar 31, 2023	Mar 31, 2023
Issue Close	Apr 05, 2023	Apr 06, 2023
Basis Of Allotment (Tentative)	Apr 11, 2023	Apr 12, 2023
Initiation of Refunds (Tentative)	Apr 12, 2023	Apr 13, 2023
Credit of Share (Tentative)	Apr 13, 2023	Apr 17, 2023
Listing date (Tentative)	Apr 17, 2023	Apr 18, 2023
Anchor Lockin End date 1	May 11, 2023	May 12, 2023
Anchor Lockin End date 2	Jul 10, 2023	Jul 11, 2023

Financials

Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Sancode Technologies IPO P/E ratio of 10.71.

Infinium Pharmachem IPO

Sancode Technologies IPO

Financial

Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	2,244.60	3,941.64	93.40	424.74	566.17
31-Mar-21	3,418.27	7,115.37	272.48	702.32	579.47
31-Mar-22	5,899.95	10,005.25	610.64	1,310.22	1,385.01
30-Sep-22	7,075.71	7,985.39	551.01	1,855.77	1,614.71
Amount in ₹ Lakhs

Sancode Technologies Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	330.45	43.08	-112.98	220.83	197.95	0.22
31-Mar-21	313.96	159.74	-26.17	223.56	200.69	63.73
31-Mar-22	349.87	244.81	75.12	287.07	264.19	20.76
30-Sep-22	481.26	180.62	89.36	367.54	344.67	21.20
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100%

97.47%

Promoter Shareholding (Post-Issue)

73.05%

71.24%

P/E Ratio

7.83

10.71

Market Cap

₹93.93 Cr.

₹19.12 Cr.

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Sancode Technologies IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 0 shares in Sancode Technologies IPO.

	Infinium Pharmachem IPO	Sancode Technologies IPO
Anchor Investor Reserveration
Market Maker Reserveration	94,000 shares	57,000 shares
QIB	0 shares	0 shares
NII	9,37,500 shares	5,19,000 shares
RII	9,37,500 shares	5,19,000 shares
Employee	0 shares	0 shares
Others
Total	18,75,000 shares	10,38,000 shares

Bids Received (Subscription)

Infinium Pharmachem IPO subscribed 1.84x in total, whereas Sancode Technologies IPO subscribed 3.68x.

	Infinium Pharmachem IPO	Sancode Technologies IPO
QIB (times)
NII (times)	1.80x	3.98x
Big NII (times)
Small NII (times)
RII (times)	1.86x	3.39x
Employee (times)
Other (times)
Total (times)	1.84x	3.68x

Compare with others

Infinium Pharmachem IPO	Sancode Technologies IPO
Pattech Fitwell Tube Components IPO	De Neers Tools IPO
Sancode Technologies IPO	Quicktouch Technologies IPO
Exhicon Events IPO	Retina Paints IPO
Sotac Pharmaceuticals IPO	A G Universal IPO
MOS Utility IPO	Pattech Fitwell Tube Components IPO
Maiden Forgings IPO	Exhicon Events IPO
Command Polymers IPO	Sotac Pharmaceuticals IPO
Dev Labtech Venture IPO	MOS Utility IPO
Nirman Agri Genetics IPO	Infinium Pharmachem IPO
Labelkraft Technologies IPO	Maiden Forgings IPO

Comments

Add a public comment...